A new sugar-based breast-cancer imaging agent set to enter human trials highlights opportunities to streamline the path from lab to clinic here at home.
Étiquette : GlycoNet
Researchers uncover how brain lipids help neurons communicate and protect themselves
GlycoNet team at the University of Alberta builds on previous work to find a new direction for potential treatment of neurodegenerative diseases like Huntington’s.
Conclusion d’un protocole d’entente entre GlycoNet et le Center for Cooperative Research in Biosciences (CIC bioGUNE) pour faire avancer la collaboration mondiale en glycomique
Together, the organizations will explore joint projects, training exchanges and shared resources.
Research Saves Lives
Dr. Lori West honoured by Heart and Stroke Foundation
De la recherche à l’innovation, pour un avenir prospère en Alberta
Grâce à un nouveau partenariat, GlycoNet et Alberta Innovates unissent leurs forces pour propulser la glycomique — la nouvelle frontière en biotechnologie — vers des solutions de santé transformatrices.
GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs
The successful transplant marks major progress towards more compatible, accessible organs for patients.
GlycoNet Investigator named a Member of the Royal Society of Canada
Congratulations to Dr. Matthew Macauley on being named a Member in the Royal Society of Canada, Canada’s highest academic honour.
New radiotracer could make breast cancer detection quicker, more accurate
GlycoNet researchers set to test new PET scan molecule in European clinical trials.
GlycoNet signs MOU with Japan’s Institute for Glyco-core Research (iGCORE), strengthening global glycomics collaboration
The agreement reflects GlycoNet’s ongoing commitment to fostering international partnerships that accelerate advancements in health, biotechnology, and sustainable agriculture.
La glycomique en pleine effervescence au cœur de Glyco27
Plus de 400 chercheurs, experts de l’industrie et jeunes talents en glycobiologie se sont réunis à Edmonton (Alberta), du 25 au 30 mai 2025, à l’occasion du 27ᵉ Symposium international sur les glycoconjugués (Glyco27), organisé conjointement avec le 8ᵉ Symposium canadien de glycomique.